Clinical Trials Directory

Trials / Completed

CompletedNCT03112226

Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Complaints about memory and thinking are common in women as they go through menopause. The female hormone estrogen is important for both the health of both the brain and the blood vessels. In Alzheimer's disease there is damage to the blood vessels in the brain. This study will look at how the loss of the female hormone estrogen affects brain function and the health of blood vessels.

Conditions

Interventions

TypeNameDescription
OTHERGnRHant + E2GnRH antagonist with estradiol add-back
OTHERGnRHant + PlaceboGnRH antagonist with placebo add-back

Timeline

Start date
2018-02-07
Primary completion
2020-06-06
Completion
2020-06-21
First posted
2017-04-13
Last updated
2021-06-07

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03112226. Inclusion in this directory is not an endorsement.